Back
SEPSECSHGNC Autosomal recessivePubMedPhenotypic expansionFunctional SNVRecurrent variant

Disease characteristics of SEPSECS deficiency: an international, retrospective, multicenter cohort study.

Killam BY, Knol MJ, Fradejas-Villar N, et al.Genet Med 2026 · August 2026
Relevance score
7/10
Disease / domain
SEPSECS-related neurodevelopmental disorder (formerly PCH2D)
Source
PubMed
PMID 42603098
Share on LinkedInBluesky

Variant / mechanism

Biallelic SEPSECS variants disrupt selenoprotein biosynthesis; variants in the conserved N- and C-termini and catalytic site cause misfolding, aggregation, thermal instability and loss of function, with oxidative stress and possible neuronal ferroptosis.

Summary

This international retrospective multicenter study describes 27 individuals with biallelic SEPSECS variants, including 13 previously unreported variants. Broad biochemical correlation, focused metabolomics, and structural and in vitro activity analyses delineate three clinical courses: severe early-onset with cerebellar or cerebral atrophy, milder early-onset with gradual deterioration, and late-onset mild disease. Involvement is primarily cerebral: in only one of eight individuals assessed did thyroid hormone measurements suggest defective T4 to T3 conversion, whereas increased plasma glutathione and sulfur metabolites indicated elevated oxidative stress. For differential diagnosis and monitoring of therapeutic attempts, the authors recommend measuring plasma selenium, glutathione and sulfur metabolites, GPX activity, and SELENOP. Because pontine involvement was present in fewer than half of cases, they propose renaming PCH2D as SEPSECS-related neurodevelopmental disorder.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

The proposed renaming is not cosmetic: using pontocerebellar hypoplasia as the radiological entry point misses more than half of cases, and this study should prompt reconsideration of SEPSECS variants dismissed on an unsuggestive MRI. The proposed biochemical panel (selenium, glutathione, sulfur metabolites, GPX, SELENOP) is the real operational contribution, but it still needs prospective validation as a differential diagnostic aid, since here it is derived from the cohort itself. With 27 patients spread across three trajectories, individual prognosis cannot yet be given from variant position alone.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 2/3Evidence 2/3Novelty 1/2Sample 1/1Publication 1/1

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 7/10

Keywords

selenoproteinsneurodevelopmental disorderataxiapontocerebellar hypoplasiametabolomics
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime